Results 201 to 210 of about 68,732 (285)

Antibodies to watch in 2026. [PDF]

MAbs
Crescioli S, Kaplon H, Chenoweth A, Hsu YS, Pinto K, Kapoor V, Reichert JM.   +6 more
europepmc   +1 more source

Six‐Year Trends in Real‐World Data Use for Post‐Marketing Surveillance of New Medical Products in Japan

Clinical and Translational Science, Volume 19, Issue 2, February 2026.
ABSTRACT The Ministerial Ordinance on Good Post‐Marketing Study Practice for Drugs was amended by the Ministry of Health, Labour and Welfare (MHLW) in 2018 to clearly define post‐marketing database studies (DBS) as a measure of pharmacovigilance activities for approved medical products in Japan.
Suguru Okami, Kako Shimotsumagari, Yasunari Sadatsuki   +2 more
wiley   +1 more source

Enhancing translational research impact through collaborative process innovation. [PDF]

J Clin Transl Sci
Palm ME, Phares S, Hirsch G.
europepmc   +1 more source

Age at onset and gene variants predict lifespan and disease duration in childhood neuronal ceroid lipofuscinoses

Developmental Medicine &Child Neurology, Volume 68, Issue 2, Page 276-286, February 2026.
This original article is commented on by Mole on pages 156–157 of this issue. Abstract Aim To address disease progression in a cohort of patients with childhood‐onset neuronal ceroid lipofuscinosis (NCL), a group of genetic disorders leading to progressive dementia. Method In this retrospective study, selected clinical features (age at onset, at death,
Alessandro Simonati, Francesco Pezzini, Nardo Nardocci, CLNet Consortium, C Aiello, R Battini, R Biancheri, M Bonsignore, R Carrozzo, B Dalla Bernardina, S Della Vecchia, S Doccini, A Donati, M Filocamo, B Garavaglia, T Granata, S Grosso, AM Laverda, V Leuzzi, C Marini, M Mastrangelo, T Messena, M Salandin, S Sartori, N Specchio, P Striano, F Taioli, A Tessa, E Veneselli, Filippo M. Santorelli   +29 more
wiley   +1 more source

Controlled access to lumasiran in primary hyperoxaluria type 1: evaluation of a new access route for orphan drugs in the Netherlands. [PDF]

Nephrol Dial Transplant
Deesker LJ, Franssen CFM, Dorresteijn E, van de Kar NCAJ, Nurmohamed SA, Severs D, Garrelfs SF, Pisters-van Roy AAMG, Hollak CEM, Groothoff JW.   +9 more
europepmc   +1 more source

Real‐World Effectiveness and Safety of Damoctocog Alfa Pegol in Severe and Nonsevere Patients With Hemophilia A From the Prospective, Multinational, Ongoing HEM‐POWR Study

European Journal of Haematology, Volume 116, Issue 2, Page 148-159, February 2026.
ABSTRACT Objectives To assess the effectiveness and safety of damoctocog alfa pegol in patients with severe and nonsevere hemophilia A in the fifth interim analysis of the ongoing HEM‐POWR study. Methods HEM‐POWR (NCT03932201) is a multinational, Phase 4, prospective observational study.
Mark T. Reding, María Teresa Alvarez Román, Giancarlo Castaman, Maissaa Janbain, Tadashi Matsushita, Karina Meijer, Kathrin Schmidt, Johannes Oldenburg   +7 more
wiley   +1 more source

Enhancing diagnostic efficiency of pyrazinamide resistance in <i>Mycobacterium tuberculosis</i> via modified MGIT assay and genotypic correlation. [PDF]

Curr Res Microb Sci
Rajendran A, Refaya AK, Subramanyam B, Karunaianantham R, RaviKumar D, Haribabu H, Gopalaswamy R, Golla R, Senthildevi V, Gomathi NS, Shanmugam S, Palaniyandi K.   +11 more
europepmc   +1 more source

Prevalence Rates of Frequent Dream Recall and Nightmares by Age, Gender and Sleep Duration in 16 Countries

Journal of Sleep Research, Volume 35, Issue 1, February 2026.
ABSTRACT The present study aimed to describe the prevalence rates of frequent (i.e., at least weekly) dream recall and nightmares with consideration for differences in age, gender and sleep duration in 16 countries using equivalent assessment methods.
Courtney J. Bolstad, Bjørn Bjorvatn, Ngan Yin Chan, Frances Chung, Yves Dauvilliers, Luigi De Gennaro, Colin A. Espie, Brigitte Holzinger, Yuichi Inoue, Maria Korman, Adrijana Koscec Bjelajac, Anne‐Marie Landtblom, Tainá Macêdo, Kentaro Matsui, Ilona Merikanto, Charles M. Morin, Sérgio Mota‐Rolim, Thomas Penzel, Giuseppe Plazzi, Cátia Reis, Serena Scarpelli, Yun Kwok Wing, Michael R. Nadorff   +22 more
wiley   +1 more source

Celebrating the 40-year milestone: NF-ĸB in oncoimmunity. [PDF]

Cancer Lett
Alipourgivi F, Lu T.
europepmc   +1 more source

Aviptadil in Acute Respiratory Distress Syndrome-Promise or Mirage? [PDF]

Indian J Crit Care Med
Chanchalani G.
europepmc   +1 more source